[1]刘媛媛,冯雪亮,张馨心.0.1 g·L阿托品不同给药频次对青少年屈光不正患者屈光度及调节功能的影响[J].眼科新进展,2023,43(3):212-216.[doi:10.13389/j.cnki.rao.2023.0043]
　LIU Yuanyuan,FENG Xueliang,ZHANG Xinxin.Effects of different administration frequencies of 0.1 g·L atropine on the diopter and accommodation function of adolescents with refraction error[J].Recent Advances in Ophthalmology,2023,43(3):212-216.[doi:10.13389/j.cnki.rao.2023.0043]
点击复制

0.1 g·L-1阿托品不同给药频次对青少年屈光不正患者屈光度及调节功能的影响/HTML
分享到：

《眼科新进展》[ISSN:1003-5141/CN:41-1105/R]

卷:
43卷
期数:
2023年3期
页码:
212-216
栏目:
应用研究
出版日期:
2023-03-05

文章信息/Info

Title:
Effects of different administration frequencies of 0.1 g·L-1 atropine on the diopter and accommodation function of adolescents with refraction error
作者:
刘媛媛; 冯雪亮; 张馨心
030001　山西省太原市，山西医科大学第一临床医学院（刘媛媛）；030000　山西省太原市，山西省眼科医院斜视与小儿眼科(冯雪亮);030000　山西省太原市，山西省眼科医院综检科(张馨心)
Author(s):
LIU Yuanyuan1; FENG Xueliang2; ZHANG Xinxin3
1.the First Clinical Medical College, Shanxi Medical University, Taiyuan 030001, Shanxi Province, China
2.Strabismus and Pediatric Ophthalmology, Shanxi Eye Hospital, Taiyuan 030000, Shanxi Province, China
3.Comprehensive Inspection Department, Shanxi Eye Hospital, Taiyuan 030000, Shanxi Province, China
关键词:
阿托品; 青少年; 近视; 给药频次; 屈光度; 调节功能
Keywords:
atropine;  adolescents;  myopia;  administration frequencies;  diopter;  accommodation function
分类号:
R778.11
DOI:
10.13389/j.cnki.rao.2023.0043
文献标志码:
A
摘要:
目的　比较0.1 g·L-1阿托品不同给药频次对青少年屈光不正患者屈光度及调节功能的影响。
方法　纳入2020年6月至2021年6月于山西省眼科医院斜视与小儿眼科门诊就诊的中度近视青少年患者123例（246眼），采用随机数字表法分为观察组（62例）、对照组（61例）。两组患者均接受0.1 g·L-1阿托品滴眼液治疗，其中对照组为每晚1滴，每天1次，观察组为每晚1滴，隔日1次，持续用药1年。比较治疗前和治疗后12个月两组患者眼轴长度、眼压、近视、等效球镜度数（SER）、瞳孔直径、前房深度、双眼调节功能等参数变化情况，并记录用药期间不良反应情况。
结果　治疗后12个月，两组患者SER均较治疗前提高，差异均有统计学意义(均为P<0.05)。治疗后1个月、4个月、8个月，两组患者SER与治疗前比较差异均无统计学意义(均为P>0.05)。治疗前，治疗后1个月、4个月、8个月以及12个月, 两组患者SER比较差异均无统计学意义(均为P>0.05)。治疗后12个月，两组患者瞳孔直径均高于治疗前（均为P<0.05），而眼轴长度、前房深度、眼压与治疗前比较差异均无统计学意义（均为P>0.05）。治疗前以及治疗后12个月，两组患者瞳孔直径、眼轴长度、前房深度、眼压比较差异均无统计学意义（均为P>0.05）。治疗前两组患者调节幅度、调节灵敏度比较差异均无统计学意义（均为P>0.05），治疗后12个月均高于治疗前（均为P<0.05）。治疗后12个月，两组患者调节幅度、调节灵敏度比较差异均无统计学意义（均为P>0.05）。不良反应多发生于用药后1个月内，主要为畏光、视近模糊、眼痒、眼胀，对照组、观察组患者不良反应发生率分别为19.67%、14.52%，差异无统计学意义（P>0.05）。
结论　0.1 g·L-1阿托品不同滴眼频次（每天1次、隔日1次）均可有效改善青少年屈光不正患者屈光度及调节功能，且疗效一致，不良反应发生率相近，均具有良好的应用价值。
Abstract:
Objective　To compare the effects of 0.1 g·L-1 atropine eye drops on the diopter and accommodation function of adolescents with refraction error at different administration frequencies.
Methods　Totally 123 adolescents (246 eyes) with medium myopia attending the Strabismus and Pediatric Ophthalmology Clinic of Shanxi Eye Hospital from June 2020 to June 2021 were included. They were divided into the observation group (n=62) and control group (n=61) using the random number table method. All received 0.1 g·L-1 atropine eye drops. Patients in the control group received 1 drop per night, while those in the observation group received 1 drop once every other night. The treatment in both groups lasted for 1 year. The axial length, intraocular pressure, myopia, spherical equivalent refractive (SER), pupil diameter, anterior chamber depth, and binocular accommodation function before and 12 months after the treatment were compared, and adverse reactions during the treatment were recorded.
Results　The SER after 12 months of treatment in both groups was higher than that before the treatment, with statistically significant differences (both P<0.05), while SER at 1 month, 4 months, and 8 months after treatment had no statistically significant difference with that at baseline (all P>0.05). The two groups had no significant difference in the SER before, 1 month, 4 months, 8 months and 12 months after the treatment (all P>0.05). The pupil diameter in the two groups 12 months after the treatment was larger than that at baseline (both P<0.05), while no statistically significant difference was found in the axial length, anterior chamber depth and intraocular pressure (all P>0.05). The two groups showed no significant difference in pupil diameter, axial length, anterior chamber depth and intraocular pressure before and 12 months after treatment (all P>0.05). The amplitude and sensitivity of accommodation before and 12 months after the treatment showed no significant difference between the two groups (all P>0.05); those significantly increased in both groups at 12 months after treatment (both P<0.05). Adverse reactions occurred mostly within 1 month after medication, mainly including photophobia, blurred near vision, eye itching and eye distension. The incidence rate of adverse reactions in the control group and observation group was 19.67% and 14.52%, with no significant difference (P>0.05).
Conclusion　Different administration frequencies of 0.1 g·L-1 atropine eye drops (once-daily vs. every-other-day) can effectively improve the diopter and accommodation function of refraction error adolescents with similar efficacy and incidence of adverse effects, as well as good application value.

参考文献/References:

［1］　GUPTA S,SINGH A,MAHALINGAM K,SELVAN H,GUPTA P,PANDEY S,et al.Myopia and glaucoma progression among patients with juvenile onset open angle glaucoma:a retrospective follow up study［J］.Ophthalmic Physiol,2021,41(3):475-485.
［2］　CHOI K Y,CHAN H H.Extrinsic and intrinsic factors regulating juvenile refractive development and eye growth ［J］.Invest Ophthalmol Vis Sci,2021,62(14):21.
［3］　ZHANG P,ZHU H.Light signaling and myopia development:a review［J］.Ophthalmol Ther,2022,11(3):939-957.
［4］　ZHANG Y,YAN H.Research progress in classification of posterior wall morphology of eyeball and its relationship with myopia related complications in high myopic eyes［J］.Chin J Exp Ophthalmology,2020,38(11):997-1000.
［5］　LI F F,YAM J C.Low-concentration atropine eye drops for myopia progression［J］.Asia Pac J Ophthalmol (Phila),2019,8(5):360-365.
［6］　YAM J C,LI F F,ZHANG X,TANG S M,YIP B H K,KAM K W,et al.Two-year clinical trial of the low-concentration atropine for myopia progression (lamp) study:phase 2 report［J］.Ophthalmology,2020,127(7):910-919.
［7］　YANG Y,LI J,WANG L,LI P,LIU W L,YAN J.Influence of orthokeratology combined with visual training on accommodation of myopic children without symptomatic dysfunction［J］.Ophthalmology,2019,28(6):421-425.
［8］　慕璟玉，王雁，杨依宁，高云仙.近视的流行病学、病因学与发病机制研究现状［J］.眼科新进展,2021,41(11):1089-1096.
MU J Y,WANG Y,YANG Y N,GAO Y X.Research status of epidemiology,etiology and pathogenesis of myopia ［J］.Rec Adv Ophthalmol,2021,41(11):1089-1096.
［9］　MAK C Y,YAM J C,CHEN L J,LEE S M,YOUNG A L.Epidemiology of myopia and prevention of myopia progression in children in East Asia:a review［J］.Hong Kong Med J,2018,24(6):602-609.
［10］　ZHANG D X.Mechanism and clinical effects of atropine on myopia progression［J］.Chin J Exp Ophthalmol,2022,40(6):594-598.
［11］　WU P C,CHUANG M N,CHOI J,CHEN H,WU G,OHNO-MATSUI K,et al.Update in myopia and treatment strategy of atropine use in myopia control［J］.Eye (Lond),2019,33(1):3-13.
［12］　CHIA A,CHUA W H,CHEUNG Y B,WONG W L,LINGHAM A,FONG A,et al.Atropine for the treatment of childhood myopia:safety and efficacy of 0.5%,0.1%,and 0.01% doses (atropine for the treatment of myopia 2)［J］.Ophthalmology,2012,119(2):347-354.
［13］　YAM J C,JIANG Y,TANG S M,LAW A K P,CHAN J J,WONG E,et al.Low-concentration atropine for myopia progression (LAMP) study:a randomized,double-blinded,placebo-controlled trial of 0.05%,0.025%,and 0.01% atropine eye drops in myopia control［J］.Ophthalmology,2019,126(1):113-124.
［14］　HA A,KIM S J,SHIM S R,KIM Y K,JUNG J H.Efficacy and safety of 8 atropine concentrations for myopia control in children:a network meta-analysis［J］.Ophthalmology,2022,129(3):322-333.
［15］　CLARK T Y,CLARK R A.Atropine 0.01% eyedrops significantly reduce the progression of childhood myopia［J］.J Ocul Pharmacol Ther,2015,31(9):541-545.
［16］　SAH R P,RAMASUBRAMANIAN V,REED O,MEYER D,BRADLEY A,KOLLBAUM P S.Accommodative behavior,hyperopic defocus,and retinal image quality in children viewing dlectronic displays［J］.Optom Vis Sci,2020,97(8):628-640.
［17］　CHEN D X,HE X G,XU X.The safety of atropine for myopia prevention and control［J］.Chin J Ophthalmol,2021,57(4):299-304.
［18］　QIN J,L Y,WEI L,ZHANG J J,ZHAO B X,FU A C.Comparison of myopia progression between different concentrations and application frequencies of atropine eye drops in children［J］.Chin J Exp Ophthalmol,2021,39(5):423-429.
［19］　FU A C,RONG J B,WANG W Q,WEI L,ZHANG J J,ZHAO B X,et al.A randomized controlled clinical study of 0.01% and 0.02% atropine eye drops on myopia development in adolescents［J］.Chin J Exp Ophthalmol,2022,40(3):253-259.
［20］　YAM J C,ZHANG X J,ZHANG Y,WANG Y M,TANG S M,LI F F,et al.Three-year clinical trial of low-concentration atropine for myopia progression (LAMP) study:continued versus washout:phase 3 report［J］.Ophthalmology,2022,129(3):308-321.

相似文献/References:

[1]朱梦钧 何鲜桂 朱剑锋.调节功能优化训练改善青少年近视裸眼视力及双眼协动参数的临床研究[J].眼科新进展,2012,32(11):000.
[2]谢祥勇 何碧华 杜惠娟 程子昂.凸透三棱镜结合视觉生理性眼操训练对青少年近视的预防控制作用[J].眼科新进展,2013,33(5):000.
[3]张娟美,吴建峰,毕宏生.青少年近视发生发展的相关环境因素及机制研究进展[J].眼科新进展,2014,34(12):1193.[doi:10.13389/j.cnki.rao.2014.0332]
　ZHANG Juan-Mei,WU Jian-Feng,BI Hong-Sheng.Recent adv ces in enviromental factors and mechanisms involved in prevalence and progression of children myopia[J].Recent Advances in Ophthalmology,2014,34(3):1193.[doi:10.13389/j.cnki.rao.2014.0332]
[4]罗铭,李红阳,马胜生,等. 青少年高度近视眼的脉络膜厚度改变[J].眼科新进展,2015,35(5):449.[doi:10.13389/j.cnki.rao.2015.0122]
　LUO Ming,LI Hong-Yang,MA Sheng-Sheng,et al. Changes of choroidal thickness in adolescent high myopia[J].Recent Advances in Ophthalmology,2015,35(3):449.[doi:10.13389/j.cnki.rao.2015.0122]
[5]贺美男,祝颖,王希莲,等.0.1g·L-1阿托品滴眼液对瞳孔直径和调节的影响[J].眼科新进展,2016,36(10):932.[doi:10.13389/j.cnki.rao.2016.0249]
　HE Mei-Nan,ZHU Ying,WANG Xi-Lian,et al.Effects of 0.1 g·L-1 atropine on pupil size and accommodation[J].Recent Advances in Ophthalmology,2016,36(3):932.[doi:10.13389/j.cnki.rao.2016.0249]
[6]荣敏娜,邓媛,邓文,等.体质量指数对青少年24 h眼压波动的影响[J].眼科新进展,2018,38(2):150.[doi:10.13389/j.cnki.rao.2018.0033]
　RONG Min-Na,DENG Yuan,DENG Wen,et al.Effects of body mass index on 24-hour intraocular pressure fluctuations in adolescences[J].Recent Advances in Ophthalmology,2018,38(3):150.[doi:10.13389/j.cnki.rao.2018.0033]
[7]裴天序,张佳欢,韩冬,等.夜戴型角膜塑形镜对青少年泪膜的影响[J].眼科新进展,2018,38(6):579.[doi:10.13389/j.cnki.rao.2018.0137]
　PEI Tian-Xu,ZHANG Jia-Huan,HAN Dong,et al.The influence of overnight orthokeratology on tear film in young adolescents[J].Recent Advances in Ophthalmology,2018,38(3):579.[doi:10.13389/j.cnki.rao.2018.0137]
[8]钟瑞英,王燕,李坤梦,等.不同年龄及不同进展程度的近视患者3种验光方法的选择时机[J].眼科新进展,2018,38(7):660.[doi:10.13389/j.cnki.rao.2018.0155]
　ZHONG Rui-Ying,WANG Yan,LI Kun-Meng,et al.The timing choice of small pupil，compound topyroamine mydriasis，atropine mydriasis optometry in myopia patients with different degree of progress and different ages[J].Recent Advances in Ophthalmology,2018,38(3):660.[doi:10.13389/j.cnki.rao.2018.0155]
[9]吴晓兰,邬一楠,王育文,等.环曲面角膜塑形镜在伴散光的青少年近视患者中的应用研究[J].眼科新进展,2018,38(8):751.[doi:10.13389/j.cnki.rao.2018.0176]
　WU Xiao-Lan,WU Yi-Nan,WANG Yu-Wen,et al.Clinical study of controlling myopia progression of adolescents with moderate-to-high corneal astigmatism wearing toric design orthokeratology[J].Recent Advances in Ophthalmology,2018,38(3):751.[doi:10.13389/j.cnki.rao.2018.0176]
[10]李静一,刘群,李长安,等.户外活动和0.1 g·L阿托品对学龄期儿童控制近视发展的疗效对比[J].眼科新进展,2019,39(2):158.[doi:10.13389/j.cnki.rao.2019.0036]
　LI Jing-Yi,LIU Qun,LI Chang-An,et al.Comparison of outdoor activities and 0.1 g·L atropine in preventing myopia progression in children[J].Recent Advances in Ophthalmology,2019,39(3):158.[doi:10.13389/j.cnki.rao.2019.0036]

备注/Memo

备注/Memo:
山西省卫生健康委科研项目（编号：2022135）
更新日期/Last Update: 2023-03-05